DRD2 and Parkinson disease: This contention leads researchers to explore the potential use of these A2AR-containing complexes as a putative therapeutic target for various diseases, such as Parkinson’s disease (PD), where modulation of the dopamine D2 receptor (i.e., D2R) by A2AR has been largely studied [9,10,11,12].